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Polycys(c Ovarian Syndrome
Laura Quinter, RN, BSN, RNC-EFM
O6erbein University, Westerville, Ohio

Underlying
Pathophysiology
I have been working in women’s health for seven
years now and have always had a par)cular interest in
women’s health issues, par)cularly the topic of
polycys)c ovary syndrome. Given its incidence and
poten)al health consequences, it is important for the
provider to be educated on this topic and consider it
among possible e)ologies for their pa)ents’
complaints. This will allow the pa)ent to receive
prompt, appropriate treatment. Correct diagnosis will
also alert the provider to the pa)ent’s increased
metabolic and cardiovascular risks, so they can
monitor the pa)ent more closely for these.
The exact e)ology and pathophysiology behind
PCOS is not well understood, but the disease seems to
result from a combina)on of reproduc)ve and
metabolic abnormali)es. This leads to chronic
hyperandrogenism and increased estrogen
concentra)on, which leads to a loss of normal
hormonal feedback. This, in turn, leads to a rise in the
levels of circula)ng LH, FSH, estradiol, and low
progesterone levels (Thornton et al., 2015). Polycys)c
ovary syndrome develops when an overproduc)on of
male hormones causes cysts to grow on a woman’s
ovaries. A gene)c component has been suspected,
and PCOS is more common in women who have a
mother or sister with PCOS (Medline Plus, 2017).

Signs and Symptoms
Symptoms of PCOS are typically related to
anovula)on and hyperandrogenism. Symptoms
usually appear within two years of puberty. Pa)ents
typically present with a spectrum of complaints
including acne, androgenic hair loss, acanthosis
nigricans, hirsu)sm, irregular vaginal bleeding,
amenorrhea and infer)lity. Many of these pa)ents
will also have other major medical comorbidi)es
along with PCOS. These include coronary artery
disease, metabolic syndrome (approximately 50
percent of these pa)ents), elevated blood pressure,
and hyperlipidemia (Thornton et al., 2015).

Signiﬁcance of Pathophysiology
“Polycys)c ovary syndrome (PCOS) aﬀects
8-10 percent of reproduc)ve-aged females,
making it the most common state of
endocrine dysfunc)on in women” (Thornton
et al., 2015). Diagnosis is some)mes missed
or delayed because pa)ents with PCOS are
oLen treated for the signs and symptoms of
the condi)on without considera)on for the
underlying syndrome. Many pa)ents receive
treatments for their speciﬁc complaints
before they are further evaluated for other
poten)al e)ologies of said complaints, which
delays diagnosis and treatment and also
causes frustra)on for the pa)ent. Some very
serious co-morbidi)es oLen accompany this
syndrome, including glucose intolerance,
hypertension, and hyperlipidemia and it is
impera)ve that the healthcare provider
recognize and address these issues
(Thornton et al., 2017).

Implica(ons for Nursing Care
The nurse should suspect PCOS in women with/
without a history of irregular periods with
complaints of acne, hirsu)sm, alopecia, acanthosis
nigricans and metabolic syndrome. Other
hyperandrogenic states must be ruled out prior to
diagnosis of PCOS. Pa)ents must be counseled
about the long dura)on of treatment, which
includes lifestyle modiﬁca)ons with diet and
exercise. The pa)ent needs to be made aware of
their risk for glucose intolerance, Type 2 diabetes,
hyperlipidemia, and heart disease. Addi)onal
targeted therapies for hirsu)sm, oligomenorrhea,
and infer)lity should be discussed. It is also
important that the nurse oﬀers emo)onal support
to pa)ents with PCOS and screens for anxiety and
depression (Madnani et al., 2013).

Introduc(on
Polycys)c ovary syndrome (PCOS) aﬀects 8-10 percent of
reproduc)ve-aged females. “…PCOS happens when a woman's
ovaries or adrenal glands produce more male hormones than
normal. PCOS causes cysts (ﬂuid-ﬁlled sacs) to grow on the
ovaries” (Medline Plus, 2017). It is one of the most common
diseases of endocrine dysfunc)on in women, but diagnosis is
some)mes missed or delayed because pa)ents with PCOS are
oLen treated for the signs and symptoms of the condi)on
without considera)on for the underlying syndrome. Pa)ents
oLen present with complaints of acne, hair loss, hirsu)sm,
irregular vaginal bleeding, and infer)lity. Many pa)ents receive
treatments for these speciﬁc complaints before they are further
evaluated for other poten)al e)ologies of said complaints
(Thornton et al., 2015).
The keys to diagnosis and treatment of this syndrome lie in
the provider’s ability to understand the diagnos)c criteria.
Treatments should be aimed at controlling the symptoms and
underlying causes of the syndrome (Thornton et al., 2015). The
prevalence of PCOS is increasing in frequency and correct
diagnosis and treatment are important because this disease puts
the pa)ent at higher risk of developing certain co-morbidi)es
such as diabetes, metabolic syndrome, heart disease, and high
blood pressure (Medline Plus, 2017). A provider should be able
to iden)fy the clinical manifesta)ons of the syndrome and u)lize
treatments to decrease hyperandrogenic symptoms, reduce
underlying metabolic abnormali)es, eliminate endometrial
hyperplasia and carcinoma, and improve ovula)on in those
pa)ents who suﬀer infer)lity (Thornton et al., 2015).

Conclusions
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